Media & Analysis
3 Q&A interviews with MVA-membersContact person
3 Q&A Interview with Anders Almgren, mayor of MVA-member, City of Lund
1) What is the vision behind Lund Innovation District? The Vision is “Global impact within walking distance”. A well-functioning ID is a cornerstone for Lund as an internationally recognized innovation hub. It is a place where unique developments take place, attracting international actors and...
3 Q& A Interview with MVA-member ProPharma Group President Jason DeGoes
Q1: Being an American company, how did you first learn about the Medicon Valley cluster? ProPharma Group is headquartered in the US, but we are very much a global organization, and our Sweden-based team has been supporting the needs of our Pharma, Biotech and Medical Device customers in the...
3 Q&A interview with Peter Birk, partner, Nordic Mentor Network for Entrepreneurship (NOME)
Q1) What are the success criteria for NOME - Nordic Mentor Network for Entrepreneurship? NOME has three overall goals and success factors: To give the most promising life science startups access to the most experienced and influential leaders in the life science industry. Access to independent and...
3 Q&A interview with Jonathan P. Gertler, MD is CEO and Managing Partner, Back Bay Life Science Advisors and Jan Upman is Senior Relationship Manager, at DNB Bank, Sweden, who partner to organize the DNB Nordic-American Healthcare Conference
For eight years, the DNB Nordic-American Healthcare Conference has been the leading US forum for US-Nordic healthcare investment and growth, bringing together promising Nordic innovation from biopharma, medtech, healthtech and health services companies to US investors, healthcare partners,...
3 Q&A with Els van Buynder, Business Development Manager at new MVA-member, Movianto
Why have you chosen to join Medicon Valley Alliance? Movianto Benelux is a leading European Supply Chain Solutions Partner offering best-in-class quality for the pharmaceutical, biotech, medical device and diagnostic industries. We have been active in the Nordic region for many years and have...
3 Q&A interview with Lin Bateson, Chief Executive at BioPartner UK, about Anglo-Nordic Life Science Days
1) What was the main attractions at this year's Anglo Nordic? I'm glad that your question is in the plural because the conference has several important elements that appeal to different types of delegates. Singling out one aspect would be too difficult! The Investors want to see new opportunities;...
3 Q&A interview with Dr. Brian Hosung Min, CEO of new MVA-member, GenScript Probio
1) What are the unique features of GenScript ProBio as a CDMO? Could you please introduce GenScript ProBio to Medicon Valley? GenScript ProBio is a subsidiary of GenScript Biotech Corporation that offers CDMO services, spanning from drug discovery to commercialization. Our proactive strategies,...
3 Q&A Interview with CEO, Kent M. Payne, new MVA-member, BioDuro-Sundia
Q1: Why has BioDuro-Sundia decided to join Medicon Valley Alliance? BioDuro-Sundia is a global Contract Research, Development, and Manufacturing Organization (CRDMO), with offerings from target identification to drug product manufacturing at commercial scale. Medicon Valley is one of the largest...
3 Q&A Interview with partner, Kristopher D. Brown, new MVA-member, Goodwin Law (US)
1) How and when did you learn about Medicon Valley in the first place? In early November 2016, I was at a nightclub in Odense with my friend, the legendary Swedish/Danish venture capitalist Peter Benson, when we ran into and found ourselves dancing with MØ who introduced us to her good friend, the...
3 Q&A Interview with Connie Sun, Senior Vice President, Global Head of Business Development, Small Molecule, MVA-member Pharmaron
Q1: What is Pharmaron known for in the life sciences industry? Pharmaron is a leading global R&D service provider for the life sciences industry, offering integrated, end-to-end solutions to support the needs of its partners around the world. With a deep commitment to customer service and...